Search results
Democrat America has declared war on Donald Trump
The Telegraph via Yahoo News· 6 days ago“Former President Donald Trump is officially a convicted felon” ABC’s LA affiliate reported moments after the jury found him guilty of falsifying...
Sequana Medical announces data on alfapump® safety and quality of life to be presented at EASL...
Benzinga· 7 hours ago...Belgium – 6 June 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today announces data from its North American pivotal POSEIDON study of the alfapump® demonstrating...
How Could a Girl in Perfect Health Come So Close to Dying?
Rolling Stone via Yahoo News· 4 days agoBlood work confirmed the cause of death: Maddy died of toxic shock. “I swore to her in the hospital...
Council Post: 14 Reasons Entrepreneurs Give Up Too Soon (And How To Avoid Doing So)
Forbes· 2 days agoSometimes, the hardest decision for an entrepreneur to make is simply figuring out when to persist,...
Visual story: a look back at South China Morning Post’s 120 years of history
South China Morning Post· 4 days agoThe South China Morning Post has been a barometer of daily life in Hong Kong since it was founded...
Opinion | What America owes long covid patients
Washington Post· 2 days agoBravo to The Post for the May 29 front-page article “For people of color with long covid, a ‘huge disparity.’” For too long, the long covid experiences...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 day agoParoxysmal Supraventricular Tachycardia Market to Show Immense Growth During the Study Period (2020-2034) | DelveInsight PR Newswire LAS VEGAS, June 5, 2024 According to DelveInsight's estimates, the paroxysmal supraventricular tachycardia market
Demon Slayer's Most Heartbreaking Character Has a Devastating Backstory
CBR.com· 3 days agoThe following contains spoilers for Demon Slayer Season 4, Episode 2, "Giyu Tomioka's Pain," now...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 1 day agoNew data from the ELATIVE® Phase III trial show 70% of patients treated with elafibranor achieved composite endpoint of slowing disease progression measured by biochemical response after 78-weeksData from the itch domain of the PBC-40 and 5-D
